Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,110 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Active, Not Recruiting

Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma

NCT04722575

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Ospedale S.M. Annunziata - Azienda USL Toscana Centro Bagno a Ripoli, Firenze, Italy
  • IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. Meldola, Forlì-Cesena, Italy
  • Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori Milan, Milano, Italy
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" Naples, Italy
View Trial Details
Active, Not Recruiting

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

NCT01989585

Conditions
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Neoplasm, +14 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
Locations
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
  • LLC Arensia Explorer Medicine Tbilisi, Georgia
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details
Active, Not Recruiting

Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis

NCT04074096

Conditions
BRAF V600 Mutation, Brain Diseases, Brain Metastases, +18 more
Locations
  • APHP - Hôpital Avicenne Bobigny, France
  • CHU de Bordeaux - Hôpital Saint André Bordeaux, France
  • GH Sud CHU Bordeaux - Hôpital Levêque Bordeaux, France
  • APHP - Hôpital Ambroise Paré Boulogne-Billancourt, France
View all 21 locations
View Trial Details

Related conditions